Found 2 results
Filters: Keyword is Antibodies, Monoclonal, Humanized [Clear All Filters]
. Instead of wasting money on aducanumab, pay for programs proven to help people living with dementia. J Am Geriatr Soc. 2021 ;69(12):3690-3692.
. Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?. JAMA Intern Med. 2021 ;181(10):1278-1280.